It could be the first new treatment for gonorrhea in 30 years. It could be the first new treatment for the infection in 30 ...

The S&P 500 rose 0.13% to close at 5,282.70 on Thursday (April 17) after a volatile trading session, though the index still ...

GSK received approval from U.K.'s medicines regulatory body to bring its blood-cancer blockbuster candidate Blenrep back to the market, enabling the British pharma giant to expand its oncology ...

GSK's Blenrep approved in the U.K. for multiple myeloma after strong phase 3 data showing improved survival in DREAMM-7 and ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

Retail underlying operating profit for 2024/25 rose 7.2% to £1.04 billion, with double-digit growth at Sainsbury's partially ...

China warns president to ‘stop whining’ over tariffs after US curbs Nvidia chip sales in trade war - It comes as President ...

Zynext Ventures USA LLC today announced its investment in Feldan Therapeutics (Feldan), a Canada-based early clinical-stage ...

S&P 500, Nikkei 225, Charles Schwab Corp, American Express Company. Read 's Market Analysis on Investing.com UK.